Jeffery Kutok - Net Worth and Insider Trading
Jeffery Kutok Net Worth
The estimated net worth of Jeffery Kutok is at least $139,009 dollars as of 2024-09-24. Jeffery Kutok is the Chief Scientific Officer of Epizyme Inc and owns about 94,563 shares of Epizyme Inc (EPZM) stock worth over $139,008. Jeffery Kutok is also the Chief Scientific Officer of Infinity Pharmaceuticals Inc and owns about 9,542 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $1. Details can be seen in Jeffery Kutok's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffery Kutok has not made any transactions after 2022-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffery Kutok
Jeffery Kutok Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffery Kutok owns 2 companies in total, including Epizyme Inc (EPZM) , and Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Jeffery Kutok’s form 4 insider trades.
Insider Ownership Summary of Jeffery Kutok
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EPZM | Epizyme Inc | 2022-04-11 | Chief Scientific Officer |
| INFIQ | Infinity Pharmaceuticals Inc | 2018-08-16 | Chief Scientific Officer |
Jeffery Kutok Latest Holdings Summary
Jeffery Kutok currently owns a total of 2 stocks. Among these stocks, Jeffery Kutok owns 94,563 shares of Epizyme Inc (EPZM) as of April 11, 2022, with a value of $139,008 and a weighting of 100%. Jeffery Kutok also owns 9,542 shares of Infinity Pharmaceuticals Inc (INFIQ) as of August 16, 2018, with a value of $1 and a weighting of 0%.
Latest Holdings of Jeffery Kutok
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EPZM | Epizyme Inc | 2022-04-11 | 94,563 | 1.47 | 139,008 |
| INFIQ | Infinity Pharmaceuticals Inc | 2018-08-16 | 9,542 | 0.00 | 1 |
Holding Weightings of Jeffery Kutok
Jeffery Kutok Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffery Kutok has made a total of 3 transactions in Epizyme Inc (EPZM) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Epizyme Inc is the sale of 2,741 shares on April 11, 2022, which brought Jeffery Kutok around $2,467.
According to the SEC Form 4 filings, Jeffery Kutok has made a total of 0 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 14,313 shares on August 16, 2018, which brought Jeffery Kutok around $28,626.
Insider Trading History of Jeffery Kutok
- 1
Jeffery Kutok Trading Performance
Jeffery Kutok Ownership Network
Ownership Network List of Jeffery Kutok
Ownership Network Relation of Jeffery Kutok
Jeffery Kutok Owned Company Details
What does Epizyme Inc do?
Who are the key executives at Epizyme Inc?
Jeffery Kutok is the Chief Scientific Officer of Epizyme Inc. Other key executives at Epizyme Inc include Chief Operating Officer Jerald Korn , Corporate Controller Joseph Beaulieu , and Chief Medical Officer Shefali Agarwal .
Epizyme Inc (EPZM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Epizyme Inc Insider Transactions
Jeffery Kutok Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffery Kutok. You might contact Jeffery Kutok via mailing address: 784 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
